Coenzyme Q10 / HER2/EBBR2 Cancer Research Results

CoQ10, Coenzyme Q10: Click to Expand ⟱
Features:
Coenzyme Q10 (CoQ10), also known as ubiquinone, is a fat-soluble antioxidant and a critical component of the mitochondrial electron transport chain, essential for ATP production. Its potential role in Alzheimer’s disease (AD) and cancer has been increasingly studied, mainly due to its effects on oxidative stress, mitochondrial function, and cellular energy metabolism.

Two types: ubiquinone(standard) vs ubiquinol(more bioavailable)

-high content in beef heart -Acts as an antioxidant, reducing ROS
-Some preclinical studies suggest CoQ10 may reduce Aβ-induced neurotoxicity
-CoQ10 is sometimes used with chemotherapy to reduce cardiotoxicity (especially with doxorubicin).
-Essential for ATP (energy) production.

-CoQ10 levels may drop by 25–40% in people taking statins.
-May support mitochondrial function in neurodegenerative diseases, including Alzheimer’s and Parkinson’s

Coenzyme Q10 exists in three redox states:
Form	         Name	          Abbreviation	Redox state
Oxidized	Ubiquinone	    CoQ10	Oxidized (labeled “Coenzyme Q10”, “CoQ10”)
Semiquinone	Ubiquinol radical   CoQ10•–	Intermediate (labeled “Ubiquinol”, “Reduced CoQ10”)
Reduced	        Ubiquinol	    CoQ10H₂	Reduced

Most supplements = ubiquinol (reduced, antioxidant)
  Ubiquinol is often preferred for cardiovascular, aging, and antioxidant-focused use.
BPM31510 = ubiquinone (oxidized) (might raise ROS in cancer cells)

>80–95% of circulating CoQ10 is ubiquinol, regardless of whether ubiquinone or ubiquinol was ingested

-CoQ10 is fat-soluble, so take it alongside meals that include nutrient-dense fats like coconut oil, butter or tallow in moderation
-initial 200-300mg/day (split during day) down to 100mg after 21 days

BPM31510: Pharmaceutical oxidized CoQ10
BPM31510 = oxidized CoQ10 (ubiquinone) in a specialized lipid formulation.
BPM31510 increases Mitochondrial ROS in cancer cells. That increase is intentional, central to its mechanism, and relatively selective for tumor cells.
BPM31510 Studies report in cancer cells:
↑ mitochondrial ROS
↑ lipid peroxidation
↓ NADPH/NADP⁺ ratio
↓ GSH/GSSG ratio
Activation of oxidative stress pathways
Cell death without classic antioxidant rescue
Importantly: Trolox, NAC, or GSH can partially blunt BPM31510 effects, confirming ROS dependence

Coenzyme Q10 (CoQ10 / Ubiquinone) — Cancer vs Normal Cell Effects
Rank Pathway / Axis Cancer Cells Normal Cells Label Primary Interpretation Notes
1 Mitochondrial electron transport (ETC) ↔ or ↓ metabolic advantage ↑ ETC efficiency Driver Mitochondrial bioenergetic support CoQ10 improves electron transport and ATP efficiency primarily in normal cells
2 Reactive oxygen species (ROS) ↓ ROS (antioxidant) ↓ ROS (strong buffering) Driver Antioxidant dominance CoQ10 limits lipid peroxidation and mitochondrial ROS production
3 Mitochondrial membrane stability ↔ stabilized (may reduce stress signaling) ↑ membrane protection Secondary Mitochondrial resilience Stabilization favors normal cells and may blunt oxidative stress-based cancer therapies
4 Inflammatory signaling (NF-κB / cytokines) ↓ inflammatory microenvironment ↓ inflammation Secondary Anti-inflammatory milieu Reduced inflammation may limit tumor promotion but is not directly cytotoxic
5 Cell proliferation ↔ or mildly ↓ ↔ Phenotypic Growth neutrality CoQ10 does not strongly inhibit proliferation in most cancer models
6 Apoptosis ↓ apoptosis (stress protection) ↓ apoptosis Phenotypic Cytoprotection Anti-apoptotic effect reflects antioxidant and mitochondrial protection


HER2/EBBR2, Human epidermal growth factor receptor 2: Click to Expand ⟱
Source:
Type:
Also called erbB-2 (or ERb-2) -Receptor tyrosine-protein kinase
HER2 is a protein that helps breast cancer cells grow quickly.
HER2/neu protein is a receptor tyrosine kinase that is normally involved in cell growth and division. However, in some cancers, the HER2/neu gene is overexpressed or mutated, leading to an overproduction of the protein. This can cause cells to grow and divide uncontrollably, leading to tumor formation.
Scientific Papers found: Click to Expand⟱
4776- CoQ10,    Antitumor properties of Coenzyme Q0 against human ovarian carcinoma cells via induction of ROS-mediated apoptosis and cytoprotective autophagy
- vitro+vivo, Ovarian, SKOV3
ROS↑, eff↓, AntiCan↑, Apoptosis↑, tumCV↓, TumCG↓, TumCCA↑, LC3s↑, ERStress↑, Beclin-1↑, Bax:Bcl2↑, HER2/EBBR2↓, Akt↓, mTOR↓,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress ⓘ

ROS↑, 1,  

Cell Death ⓘ

Akt↓, 1,   Apoptosis↑, 1,   Bax:Bcl2↑, 1,  

Kinase & Signal Transduction ⓘ

HER2/EBBR2↓, 1,  

Transcription & Epigenetics ⓘ

tumCV↓, 1,  

Protein Folding & ER Stress ⓘ

ERStress↑, 1,  

Autophagy & Lysosomes ⓘ

Beclin-1↑, 1,   LC3s↑, 1,  

Cell Cycle & Senescence ⓘ

TumCCA↑, 1,  

Proliferation, Differentiation & Cell State ⓘ

mTOR↓, 1,   TumCG↓, 1,  

Drug Metabolism & Resistance ⓘ

eff↓, 1,  

Clinical Biomarkers ⓘ

HER2/EBBR2↓, 1,  

Functional Outcomes ⓘ

AntiCan↑, 1,  
Total Targets: 15

Pathway results for Effect on Normal Cells:


Total Targets: 0

Scientific Paper Hit Count for: HER2/EBBR2, Human epidermal growth factor receptor 2
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:356  Target#:359  State#:%  Dir#:1
  wNotes=0  sortOrder:rid,rpid

 

Home Page